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Descriptive Profiles of the MMPI-2-Restructured Form (MMPI-2-RF
across a National Sample of Four Veteran Affairs Treatment Settings
Abstract
This investigation provides descriptive information on substantive scale scores from the Minnesota Multiphasic 
Personality Inventory-2-Restructured Form (MMPI-2-RF) across four common service locations within Veterans Affairs (VA): 
PTSD clinical team, individual substance use treatment, primary medical care, and residential polytrauma rehabilitation. Test 
protocols for these four service settings are drawn from a national sample of all MMPI-2-RF and converted MMPI-2 
administrations between January 1, 2008 and May 31, 2015 using the VA Mental Health Assist system at any VA across the United 
States. Frequency of substantive scale elevation and descriptive findings are examined. Results of this investigation suggest that 
there are differences between VA service locations on the MMPI-2-RF substantive scales, the magnitude of difference depends on the 
substantive scale examined, and the pattern of elevation within service location follows common clinical concerns for the settings. 
Implications for the clinical use, and research with, the MMPI-2-RF within the VA and with the veteran population are discussed.
Keywords MMPI-2-RF . Veteran affairs . Psychological assessment . Veteran
The Department of Veteran Affairs (VA) provides essential
psychological and medical services to a sizable portion of
the country’s veterans. As of 2016, the VA offered these ser-
vices at 1221 outpatient sites, 300 veteran centers, and 144 VA
hospitals (United States Department of Veterans Affairs
National Center for Veterans Analysis and Statistics 2017).
Of the projected 21.68 million veterans in the country during
2015, more than one in every three were enrolled in services at
the VA. Moreover, roughly half of all veterans have utilized at
least one service offered by the VA during any given year
(National Center for Veterans Analysis and Statistics 2016).
This high frequency of care and enrollment in services has
steadily risen for the past 15 years, with roughly a quarter of
all veterans now linked with the VA because of injuries asso-
ciated with their service (Bagalman 2014). Much like enroll-
ment, disability connection and associated care has also seen
an increase in recent years (Duggan et al. 2010). In short, the
VA is critical to promoting and improving veteran health on
the national stage (e.g., Wilson and Kizer 1997).
The VA provides services for a distinctive population facing
numerous barriers to good health and well-being. Some frequent
obstacles to receiving needed care include a variety of resource
shortages, such has having less optimal insurance coverage or a
more limited ability to pay for needed services (Nelson et al.
2007; Wilson and Kizer 1997). In addition to these resource-
based difficulties, veterans also have substantially greater mental
and physical health problems than the general public, which
makes achieving and promoting health more difficult. Those
using theVA are likely to need healthcare servicesmore frequent-
ly (Agha et al. 2000) because of higher rates of substance use
(Wagner et al. 2007), worse mental health (Hankin et al. 1999;
Hoge et al. 2006; Kaplan et al. 2007; Seal et al. 2007), and more
frequent and severe physical ailments (Kazis et al. 1998).
Increased veteran service utilization may be due, in part, to
the VA’s increased emphasis on evidenced-based treatment
and symptom assessment (Shekelle et al. 2010), including
the use of measurement-based care (Fortney et al. 2017).
This emphasis on improved mental health screening and
symptom identification is needed as there are several major
health epidemics among veterans attracting major attention,
including suicide (Kang et al. 2015) and post-traumatic stress
disorder (PTSD) (Kilpatrick et al. 2013). With VA services
utilized more (42–146%) by those qualifying for a psychiatric
diagnosis (Cohen et al. 2010), mental health assessments offer
a means to screen for these and other mental health concerns
and determine needed treatment (Seal et al. 2007, 2008).
Frequently, brief face-valid single symptom inventories
(e.g., PTSD Checklist, Patient Health Questionnaire) are used
to assess and track patient symptoms. Despite some ability to
assist in diagnostic efforts and short administration times,
there are also concerns about the effectiveness of such tools
because of problematic false positive/false negative rates
(Nelson et al. 2014). Broadband inventories, on the other
hand, tend to evidence stronger psychometrics as they typical-
ly undergo more extensive validation processes that yield
more precise and reliable symptom measurement.
Broadband instruments also measure an array of mental health
constructs rather than a single area of concern (e.g., PTSD,
depression, etc.) which makes broadband inventories well
suited to assess the numerous and often comorbid clinical
concerns common to veterans (e.g., Seal et al. 2009).
Finally, brief screening instruments do not have embedded
protocol validity indicators, yet it is important to consider
response style to ensure self-report information is not
embellished, minimized, or provided by an individual who
does not understand the test content. This need for the moni-
toring of response style is particularly pronounced within the
VA (Ray 2017; Russo 2013). Between 33% to 53% of vet-
erans undergo the forensically-intermingled compensation
evaluation process (DeViva and Bloem 2003; Freeman et al.
2008) and those evaluations can incorporate historic testing
data from the veteran’s record (Worthen and Moering 2011)
that may not reflect symptom presentation accurately if not
screened for patterns of invalid responding. Thus, broadband
measures offer a level of utility not available with brief symp-
tom inventories and are well-suited to the task of aiding VA
measurement-based care.
The Minnesota Multiphasic Personality Inventory-
Restructured Form (MMPI-2-RF; Tellegen and Ben-Porath
2008/2011) is a widely-used broadband instrument within
the VA and research has consistently supported the reliability
and validity of scores on MMPI-2-RF scales in veterans and
military service members (e.g., Russo 2018). The validity
scales consistently discriminate between valid and invalid pat-
terns of responding (Goodwin et al. 2013; Nelson et al. 2011;
Sellbom et al. 2012b; Shura et al. 2017), offering a means to
evaluate the potential for response bias within the VA (Ray
2017). Similarly, the substantive scales are useful in predicting
diagnostic presentations and identifying important clinical
concerns (Koffel et al. 2012; Gottfried et al. 2014;
Sellbom et al. 2012a; Wolf et al. 2008). Moreover, the
substantive scales have also been shown to predict treat-
ment engagement (Anestis et al. 2015; Arbisi et al. 2013)
and other treatment outcomes (Arbisi et al. 2008; Forbey
et al. 2012).
Consistent with evidence of its clinical utility with
veterans, the MMPI-2-RF Technical Manual includes
two VA comparison groups (Tellegen and Ben-Porath
2008/2011). The first is from an inpatient substance
use treatment unit and the second is from an inpatient
psychiatric ward, providing important information about
typical presentation within those settings. However,
these comparison groups were derived from MMPI-2
test administrations in the 1990’s and the interpretive
context for recent assessments differs substantially, par-
ticularly given the rise of compensation processes
(Bagalman 2014; Ray 2017). Likewise, the demographic
characteristics of those samples under-represent or ex-
clude several groups frequently cared for within the
VA. For example, the substance use comparison group
is comprised of only males and era of service under-
represents Gulf War veterans. Most importantly, the
comparison groups reported in the Technical Manual
represent a narrow band of VA clinical contexts and
variability in response style across service locations is
common (Ingram et al. 2019).
In light of the various distinct evaluative settings
common within the VA and the emphasis placed on
empirically-based assessment as part of measurement in-
formed care, an examination of MMPI-2-RF scores
across common VA treatment settings is needed. To ac-
complish this goal, this study reports substantive scale
scores across four common VA treatment settings.
Specifically, we report the descriptive characteristics of
scale scores, the frequencies of veterans who produced
clinically elevated scores on MMPI-2-RF substantive
scales, and effect sizes that describe the magnitude of
differences between settings for each substantive scale.
Method
Participants
All cases where a MMPI-2 or MMPI-2-RF were administered
between January 1, 2008 and May 31, 2015 at any VA across
the country were eligible for inclusion. Cases were included
within this investigation only if their testing that was entered
electronically into the VA Mental Health Assistant Suite and
was accessible via the Corporate Data Warehouse (CDW)
framework. A subset of four common VA treatment settings
were identified for this study: individual therapy for substance
use (SUD; ntotal = 652, nvalid = 260, 60.1% invalid), PTSD
clinical team (PCT; ntotal = 4466, nvalid = 2287, 48.8% inva-
lid), residential polytrauma and traumatic brain injury
(Polytrauma; ntotal = 1596, nvalid = 612; 61.7% invalid),
and primary care medical settings (Medical; ntotal =
8711, nvalid = 2247, 74.2% invalid). Profiles were exclud-
ed if they were deemed uninterpretable, based on standard
validity scale cut-scores (Ben-Porath and Tellegen 2008):
CNS ≥ 18, VRIN-r ≥ 80, TRIN ≥80, F-r ≥ 120, and Fp-r ≥
100.
In general, those excluded from analysis most fre-
quently demonstrate patterns of profile invalidity evi-
denced by elevations on the over-reporting scores as is
consistently observed within the VA (see Ingram et al.
2019). Generally, valid participants across the four set-
tings were demographically similar (Table 1). Veterans
in this study tended to be service connected, male, mar-
ried, and have served during Gulf War conflicts.
Protocols drawn from PCT and Polytrauma were slightly
more likely to be combat veterans and have been in a
Gulf War conflict. These trends are most pronounced
for Polytrauma. Those in SUD had higher rates of di-
vorce and lower rates of marriage than other settings;
they also had the greatest amount of missing data about
service connection.
Measures
MMPI-2-Restructured Form The MMPI-2-RF (Ben-Porath
and Tellegen 2008) is a 338 true-false item personality
measure comprised of 51 scales. The 42 substantive
scales measure various clinical constructs and the nine
validity scales are used to determine if a respondent is
engaging in non-credible responding (non-content based
invalid responding, over-reporting, under-reporting).
Although demonstrating large effect sizes, veteran status
and issues critical to veterans (e.g., PTSD, traumatic
brain injury, etc.) impact response style on the over-
reporting scales (Ingram and Ternes 2016). Given the
forensically-enmeshed nature of the evaluation setting
(Ray 2017), Ingram and colleagues (2019) recommend
the use of the most conservative cut-scores identified
within the interpretive manual for identifying invalid
profiles for work within the VA: VRIN-r ≥ 80, TRIN-
r ≥ 80, F-r ≥ 120, Fp-r ≥ 100, Fs ≥ 100, RBS ≥ 100, FBS-
r ≥ 100, L-r ≥ 80, and K-r ≥ 70. MMPI-2-RF scales
scores calculated from the 567-item MMPI-2 test book-
let are comparable to those calculated from the 338-item
MMPI-2-RF booklet (c.f., Tarescavage et al. 2015).
Procedures and Planned Analysis
The CDW electronically stores veteran medical records
from the entire United States. These data were extracted
for this study through VA Informatics and Computing
Infrastructure (VINCI). A request to the CDW was
made based on testing administrations that were coded
as including either a MMPI-2 or MMPI-2-RF. This
study extracted demographic information as well as
item-level responses for all identified administrations.
Raw item responses were used to calculate MMPI-2-
RF scale scores. To identify different treatment modali-
ties within the VA, we utilized stop codes (i.e., numer-
ical values representing different clinics in which a ser-
vice is conducted at the VA). Three of the four partic-
ipant groups utilized a single stop code (513 SUD, 540
PCT, and 197 Polytrauma); however, to ensure a prima-
ry care medical group that represented both men and
women, the women’s primary care clinic (stop code
323) and internal medicine (stop code 301) were com-
bined into a single Medical group. Information about
the referral question(s) that led to evaluation was not
available within the CDW.
Means and standard deviations were calculated for
the scales of the MMPI-2-RF, as were frequencies with
which the substantive scales exceeded T-scores recom-
mended by the interpretative guidelines. Frequency of
elevation was not calculated for the Validity Scales be-
cause all invalid protocols were excluded from analysis.
For those comparison groups with enough women to
form separate comparison groups (n > = 200), gender-
specific comparison groups were calculated. Scale dif-
ferences between the settings were also examined using
Cohen’s d effect size estimates. Cohen (1988) proposed
the following effect size classifications as guidelines for
interpreting magnitude of effect: small (|.2| or less), me-
dium (between |.2| and |.5|), and large (|.8| or greater).
Results
Descriptive statistics for the MMPI-2-RF substantive
scales, as well as the frequency with which scale scores
exceed recommended values (T ≥ 65), are provided in
Tables 2 (Validity, Higher-Order, and Restructured
Clinical) and 3 (Somatic, Cognitive, Internalizing,
Externalizing, Interpersonal, and PSY-5). Also included
in Tables 2 and 3 are the VA comparison group means
described in the MMPI-2-RF Technical Manual
(Tellegen and Ben-Porath 2008/2011). The samples from
this current study do not have a direction indicated (T
or F) on VRIN-r and TRIN-r because the descriptives
were run on reflected T-scores. Across settings, veterans
frequently exceeded clinical cut-scores for multiple
scales. The scales that were the most pronounced within
each group by scale mean and frequency of clinical
elevation generally aligned with the expected clinical
concerns for that service location: SUD had the most
frequent and pronounced elevations on scales associated
with externalizing conduct problems and substance use
(SUD, JCP, and BXD); Medical had notable somatic
(MLS) and cognitively-focused (COG and NUC) eleva-
tions; Polytrauma mean elevations occurred on scales
emphasizing a mixture of somatic (RC1, MLS) and neu-
rological (NUC, COG) complaints, as well as a tenden-
cy towards social isolation (SAV, DSF); and PCT in-
cluded internalizing (EID, RCd, RC2, RC7), avoidant
(RC6, SAV, DSF), confused and disoriented thinking
(THD, RC8), and trauma-like (AXY) elevations consis-
tent with a presentation of posttraumatic stress disorder.
PCT also had overall elevated means and clinical eleva-
tion frequencies across most scales, relative to the other
groups Table 4.
Cohen d effect sizes describing between-group dif-
ferences are reported in Tables 5 (Validity, Higher-
Order, and Restructured Clinical scales) and 5
(Somatic/Cognitive, Internalizing, Externalizing,
Interpersonal, and PSY-5 scales). Moderate to large ef-
fect sizes were frequent in comparisons between set-
tings. Relative to the other settings, SUD had the most
pronounced differences (represented by Cohen’s d
values) on BXD (.43 to .61), RC1 (−.46 to −.54),
RC4 (.50 to .78), SUD (.62 to 1.08), JCP (.38 to
.48), and DISC-r (.48 to .67). Veterans on PCT were
the most dissimilar from other service locations on
RCd (.24 to .50), RC7 (.31 to .54), and AXY (.42 to
.55). Polytrauma was distinct from other groups on
EID (.21 to .56), HPC (.25 to .67), and DSF (.24 to
.56). Those within the Medical group also had moder-
ate to large effect differences from other groups; how-
ever, except for INTR-r (.62 to 1.03), effect sizes did
not consistently indicate dissimilarity from all other
groups.
Table 1 Demographic
characteristics of participants SUD PCT Polytrauma Medical
n = 260 n = 2287 n = 612 n = 2247
Marital Status
Single / Separated 81 (31.2%) 615 (26.9%) 159 (26.0%) 516 (22.9%)
Married 65 (25.0%) 937 (41.0%) 308(50.3%) 1088 (48.4%)
Divorced 110 (42.3%) 689 (30.1%) 135 (22.1%) 534 (23.8%)
Widow/Widower 3 (1.2%) 32 (1.4%) 2 (0.3%) 51 (2.3%)
Other/Missing 1 (0.4%) 14 (0.6%) 8 (1.4%) 58 (2.6%)
Period of Service
World War II – 1 (<0.0%) – 4 (0.2%)
Korea – 9 (0.4%) – 12 (0.5%)
Vietnam-Era 55 (21.2%) 673 (29.4%) 57 (9.3%) 835 (37.2%)
Post-Vietnam 78 (30.0%) 301 (13.2%) 59 (9.6%) 196 (8.7%)
Gulf War 123 (47.3%) 1287 (56.3%) 486 (79.4%) 1152 (51.3%)
Other/Missing 4 (1.6%) 16 (1.1%) 10 (1.6%) 42 (1.9%)
Service Connection
NSC – 322 (14.1%) 63 (10.3%) 267 (11.9%)
0% 5 (1.9%) 31 (1.4%) 5 (0.8%) 31 (1.4%)
10–30% 39 (15.0%) 208 (9.1% 63 (10.4%) 301 (13.4%)
31–50% 19 (7.3%) 212 (9.3%) 48 (7.8%) 307 (13.7%)
51–70% 37 (14.3%) 526 (23.0%) 106 (17.3%) 492 (21.9%)
71–99% 37 (14.3%) 537 (23.5%) 191 (31.2%) 528 (23.5%)
100% 31 (11.9%) 451 (19.7%) 136 (22.2%) 321 (14.3%)
Missing 92 (35.4%) 322 (14.1%) – –
Male 239 (91.9%) 1923 (84.1%) 528 (86.3%) 1968 (87.6%)
Combat Veteran 26 (10.0%) 305 (13.3%) 120 (19.6%) 224 (10.0%)
NSC Non service connected. This indicates that an individual was either not evaluated for service connection or
that their evaluation indicated the presenting problem was not related to their military service. Information of
education level is not coded within the electronic medical record and, thus, was not avaliable as demographic
information. Age was not coded within the database used for analysis. SUD = individual substance use treatment,
PCT = PTSD clinical teams, Polytrauma = residential polytrauma units, Medical = medical care settings. A -
indicates no records exist which match that cell’s description
Only the PCT and Medical groups had a sufficient sample
size for calculating gender-specific comparison groups
(Tables 6 and 7). Scores were generally similar for males
and females on PCT with most effect sizes falling in the
small to insignificant classification with most scales not
exceeding thresholds for clinical significance. Of the mi-
nority of scales with medium to large effects (n = 6;
11.5%), females experienced greater internalizing symp-
toms (particularly related to fearfulness and self-image)
and somatic concerns while males frequently had more ex-
ternalizing scale elevations. The most notable differences
existed for the DISC-r and AGGR-r scales across both
mean and elevation frequency. The Medical group had a
similar pattern with externalizing behaviors being higher
in males and internalizing symptoms being lower in fe-
males; however, substantive differences of effect size were
evident across a greater number of scales. Most differences
were small although there were also more medium to large
effects than seen in PCT.
Discussion
This study provides descriptive statistics for four com-
mon VA treatment settings using a national sample.
Such an investigation was warranted as existing veteran
comparison groups have limited generalizability.
Existing comparison groups were established during
the 1990’s when the forensically enmeshed compensa-
tion procedures were less frequent. Prior comparison
groups also under-represent frequently cared for groups
within the VA and describe only a narrow band of
available VA clinical settings. Accordingly, this study
expands available comparison groups for veterans with
the MMPI-2-RF and offers the most up-to-date repre-
sentation of substantive scale responses currently ob-
served within these settings. Findings from this descrip-
tive analysis of the MMPI-2-RF substantive scales are
discussed below and addressing four trends: (a) the sub-
stantive scale scores differ across VA service locations,
Table 2 Validity, Higher Order (H-O), and Restructured Clinical (RC) scale descriptive information
Scale Study Samples MMPI-2-RF Comparison Groups (VA Hospital, Men)
SUD PCT Polytrauma Medical Psychiatric Inpatient Substance Abuse Treatment
M SD % ≥ 65 M SD % ≥ 65 M SD % ≥ 65 M SD % ≥ 65 M SD M SD
Validity – – – – – – – – – – – – – – – –
VRIN-r 54 10 – 52 10 – 52 10 – 52 10 – 53 10 54 10
TRIN-r 56 7 – 57 7 – 57 7 – 57 7 – 53 T 1 52 T 1
F-r 79 20 – 84 20 – 77 20 – 78 20 – 84 28 77 27
Fp-r 62 14 – 66 14 – 61 14 – 62 14 – 62 15 59 15
Fs 68 20 – 77 20 – 72 19 – 72 20 – 70 21 66 20
FBS-r 65 14 – 74 14 – 72 14 – 71 15 – 68 15 58 15
RBS 70 17 – 60 17 – 78 17 – 76 17 – 72 20 64 18
L-r 52 11 – 55 10 – 56 10 – 55 10 – 53 11 53 10
K-r 42 9 – 39 9 – 43 10 – 42 10 – 42 10 42 10
H-O – – – – – – – – – – – – – – – –
EID 66 13 68.6 69 12 68.6 62 13 48.0 66 13 55.7 68 14 62 14
THD 61 13 36.1 62 13 36.1 57 12 20.6 58 12 25.1 61 17 60 16
BXD 62 12 26.0 57 11 36.0 55 11 21.2 55 11 20.1 58 13 66 11
RC – – – – – – – – – – – – – – – –
RCd 66 13 66.5 69 12 66.5 63 12 45.6 65 12 53.2 68 13 63 14
RC1 65 13 72.1 72 13 72.1 72 13 72.4 71 13 68.6 65 15 62 15
RC2 65 15 68.0 70 15 68.0 63 15 46.7 68 16 59.9 67 16 58 15
RC3 57 12 35.3 58 12 35.3 56 11 28.3 57 12 31.5 55 12 60 12
RC4 65 12 33.9 59 12 33.9 56 11 22.2 56 11 23.4 60 13 69 11
RC6 63 14 42.9 62 13 42.9 58 12 28.6 60 13 35.5 64 18 64 15
RC7 61 13 55.9 65 13 55.9 58 13 34.3 61 13 43.5 61 14 59 14
RC8 62 13 46.7 64 13 46.7 60 12 33.3 60 12 33.9 61 15 61 15
RC9 53 10 13.1 53 10 11.4 53 11 16.2 52 10 11.4 52 12 57 12
Comparison group descriptives are reproduced fromMMPI-2-RF Technical byYossef S. Ben-Porath and Auke Tellegen. Copyright © 2008, 2011 by the
Regents of the University of Minnesota. Reproduced by permission of the University of Minnesota Press. All rights reserved. BMinnesota Multiphasic
Personality Inventory-2-RF®^ and BMMPI-2-RF®^ are trademarks owned by the Regents of the University of Minnesota
(b) higher rates of elevation occur on scales assessing
common clinical concerns in a given setting, (c) in gen-
eral, the high frequency of clinical elevation across
scales is consistent with the high rate of mental and
physical health needs for veterans, and (d) use of non-
gendered norms are supported although gender-specific
comparison groups offer useful, incremental information.
Those seeking services for individual substance use
treatment report historic Juvenile Conduct Problems
as well as current Behavioral and Externalizing
Dysfunction and Substance Abuse. Those who were
assessed on a PCT are characterized by elevations
con s i s t e n t w i t h d i agno s t i c c r i t e r i a o f PTSD
(American Psychiatric Association 2013), including
intrusive symptoms (Criteria B), avoidant and num-
bering behaviors (Criteria C), and negatively internal-
ized thoughts and emotions (Criteria D). This align-
ment with PTSD diagnostic criteria is consistent with
Table 3 Somatic/cognitive, internalizing, externalizing, interpersonal, and PSY-5 scale descriptive information
Study Samples MMPI-2-RF Comparison Groups (VA Hospital, Men)
SUD PCT Polytrauma Medical Psychiatric Inpatient Substance Abuse Treatment
Scale M SD % ≥ 65 M SD % ≥ 65 M SD % ≥ 65 M SD % ≥ 65 M SD M SD
Somatic/Cognitive – – – – – – – – – – – – – – – –
MLS 68 13 57.3 74 11 77.1 70 13 64.7 72 12 70.9 69 13 64 13
GIC 59 15 28.8 67 16 48.5 62 16 36.1 65 17 41.5 61 17 58 16
HPC 60 12 38.8 65 12 56.4 68 12 64.7 64 12 52.7 59 13 57 13
NUC 65 14 55.4 70 14 70.7 72 14 75.3 70 14 71.0 66 16 62 16
COG 68 15 55.0 72 14 68.2 75 13 77.6 69 15 58.6 67 16 61 16
Internalizing – – – – – – – – – – – – – – – –
SUI 59 17 45.0 59 17 45.5 53 15 26.3 57 16 39.6 73 25 64 22
HLP 58 15 31.5 61 14 38.4 56 14 23.4 61 15 38.8 63 15 54 14
SFD 61 13 49.6 61 12 52.9 57 12 36.9 59 12 42.9 63 12 58 13
NFC 59 12 32.7 59 12 30.7 56 11 18.6 57 12 25.5 60 13 57 12
STW 59 12 45.4 62 12 51.9 58 12 40.0 59 12 43.8 61 12 58 12
AXY 70 17 61.9 78 16 80.7 69 17 59.3 71 17 63.2 67 19 62 17
ANP 58 12 33.8 63 12 56.7 60 13 45.1 61 13 45.7 58 13 56 13
BRF 57 13 23.8 59 13 25.6 55 12 30.2 57 13 17.9 57 13 56 12
MSF 48 9 8.5 49 9 9.2 46 7 2.9 48 9 8.0 49 9 51 9
Externalizing – – – – – – – – – – – – – – – –
JCP 60 13 33.5 55 12 19.1 55 13 20.6 54 12 16.7 59 13 64 12
SUB 65 13 51.5 57 13 24.1 52 11 10.9 54 12 15.9 56 14 73 13
AGG 58 13 31.5 60 12 35.3 56 12 26.5 57 13 29.8 56 14 59 14
ACT 53 13 23.1 52 12 17.2 51 12 16.7 50 11 13.0 52 13 53 12
Interpersonal – – – – – – – – – – – – – – – –
FML 57 12 23.5 57 12 23.7 54 11 16.2 54 12 17.0 57 13 57 13
IPP 49 10 8.1 49 10 9.3 47 9 5.7 49 10 8.3 51 11 46 9
SAV 61 14 50.0 67 13 66.2 61 14 45.9 65 13 59.4 59 14 55 13
SHY 53 11 21.9 53 11 22.9 50 10 14.9 53 10 21.0 55 11 53 11
DSF 62 16 42.3 68 17 57.6 59 15 37.1 64 17 49.0 60 16 58 15
PSY-5 – – – – – – – – – – – – – – – –
AGGR-r 53 12 22.3 55 12 27.7 56 12 27.7 54 12 25.4 51 11 58 11
PSYC-r 59 13 33.5 61 13 35.8 56 12 35.8 58 12 26.4 61 16 60 16
DISC-r 61 11 35.0 55 10 19.5 56 10 19.5 54 10 16.0 56 11 64 11
NEGE-r 62 13 48.1 66 13 57.6 60 13 57.6 63 13 46.6 63 14 61 14
INTR-r 62 14 44.2 68 14 60.6 61 15 60.6 53 15 53.0 62 15 55 14
Comparison group descriptives are reproduced fromMMPI-2-RF Technical byYossef S. Ben-Porath and Auke Tellegen. Copyright © 2008, 2011 by the
Regents of the University of Minnesota. Reproduced by permission of the University of Minnesota Press. All rights reserved. BMinnesota Multiphasic
Personality Inventory-2-RF®^ and BMMPI-2-RF®^ are trademarks owned by the Regents of the University of Minnesota
higher scores on the Anxiety scale, which is associat-
ed with various manifestations of PTSD (Sellbom
et al. 2012a). The Medical and Polytrauma groups
both had higher Cognitive Complaints, Neurological
Complaints, and a sense of Malaise which likely re-
flects some health concerns common in both of these
treatment settings. Those in Polytrauma also endorse
higher Social Avoidance and Disaffi l iat iveness,
reflecting a similarity with those seeking PTSD
treatment.
Variation in the frequency of clinically significant
scale elevations across groups occurred in a similar pat-
tern as the mean difference analyses, which also sup-
ported the distinct presenting concerns and treatment
needs for veterans across different VA settings. Of note,
clinically significant elevations were relatively common
across settings, which likely reflects the high rate of
complex and comorbid mental health needs of veterans,
as well as the centrality of trauma-experiences to their
difficulties. To some extent, these elevations may also
be due to the frequency of compensation and pension
evaluations, which may impact response style in spite of
invalid responding detection methods (e.g., Ingram et al.
2019; Nelson et al. 2011; Ray 2017).
Several trends are evident when current study find-
ings are contrasted to the comparison groups provided
in the technical manual (i.e., psychiatric inpatient and
residential substance use treatment). Anxiety, Social
Avoidance, Disaffiliativeness, and Somatic Concerns
are consistently higher in veterans from the more re-
cent sample. These moderately-sized differences likely
reflect the broader scope of the current groups (e.g.,
the inclusion of a medical group) as well as the in-
creasing centrality of trauma in the psychological and
physical health of veterans receiving VA services
(Fulton et al. 2014; Possemato et al. 2010; Seal et al.
2009).
Reflecting that the MMPI-2-RF comparison groups
target different VA populations, the psychiatric inpatient
comparison group has substantially higher Suicidal/
Table 4 Cohen d effect sizes for
the validity, Higher-order, and
restructured clinical scales
Scale Compared Groups
SUD-
PCT
SUD-
PolyTrauma
SUD-
Medical
PCT-
PolyTrauma
PCT-
Medical
PolyTrauma-
Medical
Validity – – – – – –
VRIN-r 0.20 0.20 0.20 0.00 0.00 0.00
TRIN-r −0.14 −0.14 −0.14 0.00 0.00 0.00
F-r −0.25 0.10 0.05 0.35 0.30 −0.05
Fp-r −0.29 0.07 0.00 0.36 0.29 −0.07
Fs −0.45 −0.21 −0.21 0.26 0.25 0.00
FBS-r −0.64 −0.50 −0.41 0.14 0.21 0.00
RBS 0.59 −0.47 −0.35 −1.06 −0.94 0.12
L-r −0.29 −0.38 −0.38 −0.10 0.00 0.10
K-r 0.33 −0.11 0.00 −0.42 −0.32 0.10
H-O – – – – – –
EID −0.24 0.31 0.00 0.56 0.24 −0.31
THD 0.08 0.32 0.24 0.40 0.32 −0.08
BXD 0.43 0.61 0.61 0.18 0.18 0.00
RC – – – – – –
RCd −0.24 0.24 0.08 0.50 0.33 −0.17
RC1 −0.54 −0.54 −0.46 0.00 0.08 0.08
RC2 −0.33 0.13 −0.19 0.47 0.13 −0.32
RC3 −0.08 0.09 0.00 0.17 0.08 −0.09
RC4 0.50 0.78 0.78 0.26 0.26 0.00
RC6 0.07 0.38 0.22 0.32 0.15 −0.16
RC7 −0.31 0.23 0.00 0.54 0.31 −0.23
RC8 −0.15 0.78 0.16 0.32 0.32 0.00
RC9 0.00 0.00 0.10 0.00 0.10 0.10
A positive value reflect a higher mean for the first group listed in the compared dyad
Death Ideation scores than the groups included in this
study. This scale is reliably associated with risk of self-
harm (Gottfried et al. 2014) that could lead to psychi-
atric hospitalization. Along the same lines, the psychiat-
ric inpatient comparison group had a slightly more ele-
vated Ideas of Persecution scale score than settings
identified within this study. The residential substance
use treatment comparison group had higher Substance
Abuse and Disconstraint scores, consistent with issues
expected among individuals with severe addictive be-
haviors (Bryant and McNulty 2017).
Evaluation of gender differences in the PCT and
Medical groups offers both support for the MMPI-2-
RF’s use of non-gendered norms as well as nuanced
comparison groups which should be used during inter-
pretations. In general, differences between genders on
PCT follow a pattern of more internalizing symptoms
for females and greater externalizing symptoms for
males. Most scales do not differ at a substantial mag-
nitude and, importantly, the scales central to the as-
sessment of PTSD do not vary substantially between
genders (e.g., AXY, RCd, SFD, ANP, and SAV;
Table 5 Cohen d effect sizes for
Somatic, cognitive, internalizing,
externalizing, interpersonal, and
PSY-5 scales
Scale Compared Groups
SUD-
PCT
SUD-
PolyTrauma
SUD-
Medical
PCT-
PolyTrauma
PCT-
Medical
PolyTrauma-
Medical
Somatic/Cognitive – – – – – –
MLS −0.50 −0.15 −0.32 0.33 0.17 −0.16
GIC −0.52 −0.19 −0.37 0.31 0.12 −0.18
HPC −0.42 −0.67 −0.33 −0.25 0.08 0.33
NUC −0.36 −0.50 −0.36 −0.14 0.00 0.14
COG −0.28 −0.50 −0.07 −0.22 0.21 0.43
Internalizing – – – – – –
SUI 0.00 0.37 0.12 0.37 0.12 −0.26
HLP −0.21 0.14 −0.20 0.36 0.00 −0.34
SFD 0.00 0.32 0.16 0.33 0.17 −0.17
NFC 0.00 0.26 0.17 0.26 0.17 0.26
STW −0.25 0.08 0.00 0.33 0.25 −0.08
AXY −0.48 0.06 −0.06 0.55 0.42 −0.12
ANP −0.42 −0.16 −0.24 0.24 0.16 −0.08
BRF −0.15 0.16 0.00 0.32 0.15 −0.16
MSF −0.11 0.16 0.00 0.37 0.11 −0.25
Externalizing – – – – – –
JCP 0.40 0.38 0.48 0.00 0.08 0.08
SUB 0.62 1.08 0.88 0.42 0.24 −0.17
AGG −0.16 0.16 0.08 0.33 0.24 −0.08
ACT 0.08 0.16 0.25 0.08 0.17 0.09
Interpersonal – – – – – –
FML 0.00 0.26 0.25 0.26 0.25 0.00
IPP 0.00 0.21 0.00 0.21 0.00 −0.21
SAV −0.44 0.00 −0.30 0.44 0.15 −0.30
SHY 0.00 0.29 0.00 0.29 0.00 −0.30
DSF −0.36 0.19 −0.12 0.56 0.24 −0.31
PSY-5 – – – – – –
AGGR-r −0.17 −0.25 −0.08 −0.08 0.08 0.17
PSYC-r −0.15 0.24 0.08 0.40 0.24 −0.17
DISC-r 0.57 0.48 0.67 −0.10 0.10 0.20
NEGE-r −0.31 0.15 −0.08 0.46 0.23 −0.23
INTR-r −0.43 0.07 0.62 0.48 1.03 0.53
A positive value reflects a higher mean for the first group listed in the compared dyad
Sellbom et al. 2012a). The most pronounced differ-
ences emerged on the PSY-5 scales with males
exhibiting personality traits associated with greater ag-
gression with poorer behavioral constraint. The
Medical group had differences between genders across
most of the scales; however, these differences were
small in effect for all somatic and cognitive scales.
Otherwise, elevations followed a similar pattern as
seen in the PCT group and elsewhere (e.g., males re-
port more frequent externalizing behavior problems and
females have more internalizing symptoms).
In sum, MMPI-2-RF scores reflect clinical needs that
vary depending on their reason for receiving services,
and this variability is consistent with the diversity of
physical and mental health needs of veterans treated
across VA service locations. Accordingly, the results of
this study offer support and guidance for use of the
MMPI-2-RF as a contextually sensitive measure of
physical and mental health in veterans. The pattern
and frequency of substantive scale elevations observed
in this study also highlight the importance of using cur-
rent and contextually-appropriate comparison groups
when evaluating the MMPI-2-RF within a veteran
population.
Results should be considered within the context of
this study’s limitations. First, this investigation does
not include external criteria on which to evaluate the
criterion validity of MMPI-2-RF substantive scale
scores. Although research has consistently supported
scales as measuring their intended content for veterans,
the magnitude of these associations has not been exam-
ined as a function of treatment settings. Thus, further
context-specific evaluation of extra-test criteria would
be useful in understanding differences in scores across
evaluation settings. Second, owing to limitations im-
posed by the VA database used, some important demo-
graphic information was not available within this study
(i.e., age, ethnicity, and education level of respondents).
Likewise, absent more specific referral information, it is
not possible to determine the precise clinical issues
Table 6 PCT and medical comparison groups for the validity, Higher-order, and restructured clinical scales by gender
PCT Medical
Males (n = 1923) Females (n = 364) Males (n = 1968) Females (n = 279)
Scale M SD % ≥ 65 M SD % ≥ 65 d M SD % ≥ 65 M SD % ≥ 65 d
Validity
VRIN-r 52.7 9.6 – 53.3 9.4 – 0.07 53.0 9.9 – 51.8 9.5 – 0.12
TRIN-r 57.3 6.6 – 57.0 6.4 – 0.05 57.5 6.6 – 57.5 6.7 – 0.00
F-r 85.0 19.6 – 83.4 19.1 – 0.08 78.5 19.6 – 79.3 20.1 – 0.04
Fp-r 66.3 13.4 – 65.9 13.8 – 0.03 63.0 13.9 – 64.0 14.2 – 0.00
Fs 77.1 19.9 – 77.8 19.6 – 0.04 73.5 19.2 – 75.8 20.6 – 0.12
FBS-r 73.5 14.0 – 78.5 13.9 – 0.36 71.4 14.5 – 78.3 14.4 – 0.48
RBS 80.0 16.8 – 80.5 16.1 – 0.03 76.5 16.8 – 79.2 16.5 – 0.16
L-r 55.3 10.1 – 55.0 11.5 – 0.03 55.6 10.0 – 53.7 9.7 – 0.19
K-r 39.8 9.2 – 40.2 8.7 – 0.04 41.7 9.5 – 41.8 9.4 – 0.01
H-O
EID 68.9 12.3 60.6% 71.6 11.9 75.0% 0.22 65.4 12.9 55.1% 70.4 12.8 69.8% 0.39
THD 61.8 13.5 36.8% 61.0 12.1 32.4% 0.06 57.8 12.0 24.2% 57.4 11.7 20.5% 0.03
BXD 57.6 11.2 29.1% 51.4 9.6 9.9% 0.59 54.7 10.5 19.0% 49.3 9.5 8.3% 0.54
RC
RCd 68.4 11.7 65.3% 70.6 10.9 73.1% 0.19 64.6 12.1 51.3% 69.1 11.4 66.9% 0.38
RC1 71.8 13.0 71.9% 74.7 14.1 73.1% 0.21 71.2 12.5 70.3 74.9 13.3 75.9% 0.30
RC2 70.0 14.5 67.5% 71.4 14.4 70.6% 0.10 67.7 15.5 59.5% 71.0 15.6 68.3% 0.21
RC3 58.4 11.6 35.5% 58.3 11.9 34.3% 0.01 57.4 11.6 32.0% 55.7 11.5 25.5% 0.15
RC4 59.4 11.6 64.8% 56.9 10.8 27.2% 0.22 55.7 10.7 23.0% 53.4 10.0 13.3% 0.22
RC6 62.2 13.3 42.5% 62.6 13.0 45.1% 0.03 59.0 12.9 33.2% 60.5 13.3 40.6% 0.11
RC7 64.7 12.6 54.7% 67.3 12.8 62.1% 0.20 61.2 12.9 44.9% 64.5 12.8 56.1% 0.05
RC8 64.4 12.8 47.6% 62.5 12.2 41.8% 0.15 60.2 12.1 33.5% 58.7 11.8 29.9% 0.13
RC9 53.3 10.3 14.5% 48.4 8.9 6.0% 0.51 51.9 10.1 11.7% 48.2 9.7 6.1% 0.37
leading to the evaluation; however, stop codes do pro-
vide some information about likely clinical needs.
Along the same lines, it was not possible to identify
groups of veterans receiving inpatient psychiatric or
substance abuse treatment to directly compare current
MMPI-2-RF scores in these settings to the pre-existing
MMPI-2-RF comparison groups.
Despite these limitations, this study supplements
available information on use of, and research with, the
MMPI-2-RF in veterans receiving care at the VA. This
study documents a pattern of scale elevation for
common presenting concerns that varies by treatment
setting in expected ways. It also reports descriptive
findings for these settings, which in turn provides con-
temporary comparison group data that can be used to
guide veteran care in these settings.
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Table 7 PCT and medical comparison groups for somatic, cognitive, internalizing, externalizing, interpersonal, and PSY-5 scales by gender
PCT Medical
Males (n = 1923) Females (n = 364) Males (n = 1968) Females (n = 279)
Scale M SD % ≥ 65 M SD % ≥ 65 d M SD % ≥ 65 M SD % ≥ 65 d
Somatic/Cognitive
MLS 73.5 11.4 76.6% 74.5 10.8 79.7% 0.09 71.9 12.1 70.5% 74.3 12.3 75.2% 0.20
GIC 66.0 16.3 46.7% 71.7 16.0 58.0% 0.35 64.8 16.6 42.5% 69.6 17.4 52.5% 0.28
HPC 64.8 12.1 54.8% 68.2 12.5 64.6% 0.28 63.8 11.4 50.4% 69.5 12.3 70.5% 0.48
NUC 70.6 14.3 71.3% 69.7 14.7 67.6% 0.17 70.2 13.6 72.7% 69.5 13.9 68.3% 0.05
COG 72.3 14.0 68.1% 72.9 13.4 69.0% 0.04 69.2 14.5 58.2% 71.0 13.7 60.8% 0.13
Internalizing
SUI 59.1 17.4 45.8% 58.6 17.6 43.7% 0.03 56.5 16.3 38.7% 58.9 17.2 45.7% 0.14
HLP 61.1 14.3 38.6% 60.6 14.9 37.4% 0.03 60.7 14.8 38.1% 62.5 15.1 42.8% 0.12
SFD 60.9 12.2 50.9% 64.6 12.0 63.2% 0.31 58.6 12.2 41.6% 63.1 11.9 57.9% 0.37
NFC 58.6 11.8 28.4% 63.0 12.3 42.9% 0.37 57.0 11.5 22.9% 61.0 12.0 38.1% 0.34
STW 61.3 11.9 51.2% 62.4 11.6 55.5% 0.09 58.8 12.0 41.5% 63.3 11.8 58.3% 0.38
AXY 78.3 15.6 80.5% 78.9 15.7 81.7% 0.04 72.5 17.0 66.6% 75.5 16.9 74.8% 0.18
ANP 63.9 12.5 58.5% 60.7 12.0 47.3% 0.26 61.6 13.1 45.8% 60.9 13.0 45.3% 0.05
BRF 58.3 12.6 22.3% 64.5 14.7 43.1% 0.45 56.3 12.1 16.3% 62.2 15.1 34.2% 0.43
MSF 48.2 8.5 7.2% 53.0 10.4 20.1% 0.51 47.7 8.2 6.4% 52.6 9.8 18.0% 0.54
Externalizing
JCP 55.8 12.7 20.9% 52.6 10.7 9.6% 0.27 53.9 11.9 15.4% 50.3 10.7 9.4% 0.32
SUB 56.9 13.1 25.2% 54.5 12.3 18.4% 0.19 53.9 12.0 16.8% 50.6 10.3 10.4% 0.30
AGG 60.5 12.6 38.7% 54.7 10.5 17.0% 0.50 57.6 12.8 31.5% 53.6 11.3 19.1% 0.33
ACT 51.3 11.3 16.2% 52.8 12.6 22.5% 0.13 49.3 10.8 11.7% 50.8 11.9 16.9% 0.13
Interpersonal
FML 55.9 11.6 71.1% 61.1 12.6 37.4% 0.43 53.1 11.0 14.8% 58.9 13.2 29.9% 0.48
IPP 47.8 10.0 8.0% 52.3 11.4 15.9% 0.42 48.2 9.7 7.5% 52.5 11.7 15.5% 0.40
SAV 66.9 12.5 67.3% 64.8 13.3 60.7% 0.16 65.4 12.9 62.9% 64.8 13.3 59.7% 0.46
SHY 53.1 10.5 21.8% 55.0 10.9 28.3% 0.18 52.7 10.2 19.7% 55.2 11.8 29.9% 0.23
DSF 68.1 17.4 58.5% 65.1 16.9 53.3% 0.17 65.3 17.3 50.2% 62.9 16.1 46.4% 0.14
PSY-5
AGGR-r 56.3 12.0 31.0% 48.8 10.2 10.2% 1.57 55.2 11.5 26.2% 49.0 10.5 12.9% 0.56
PSYC-r 61.0 13.0 46.2% 59.5 11.4 29.9% 0.12 57.4 11.9 25.4% 56.9 11.3 22.3% 0.04
DISC-r 56.3 10.3 22.3% 49.5 8.3 4.4% 0.73 54.4 9.5 15.7% 47.4 8.3 4.0% 0.78
NEGE-r 66.0 12.9 56.6% 67.2 12.3 62.9% 0.10 62.8 13.3 47.5% 66.4 13.0 60.1% 0.27
INTR-r 68.5 14.0 61.0% 67.6 14.5 58.2% 0.06 67.2 14.6 55.5% 68.2 14.7 56.1% 0.07
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